Skip to main content
. Author manuscript; available in PMC: 2016 Jun 19.
Published in final edited form as: AIDS. 2015 Jun 19;29(10):1173–1182. doi: 10.1097/QAD.0000000000000686

Figure 2.

Figure 2

Time to loss of maintaining durability by HBV therapy group and baseline HBV DNA level stratified at 20,000 IU/ml. Durability is defined as a composite of: i) Maintaining a ≥ 1 log IU/mL HBV DNA decline from baseline or ii) maintaining HBV DNA < 200 IU/mL if baseline HBV DNA was < 2000 IU/mL. The numbers at each week describe the number of participants who were at risk of not maintaining durability. There were only a limited number of participants who were at risk for not maintaining durability at week 144.